In vivo hematopoietic stem cell modification by mRNA delivery

被引：124

作者：

Breda, Laura ^{[1
]}

Papp, Tyler E. ^{[2
]}

Triebwasser, Michael P. ^{[1
,3
]}

Yadegari, Amir ^{[2
]}

Fedorky, Megan T. ^{[1
]}

Tanaka, Naoto ^{[1
]}

Abdulmalik, Osheiza ^{[1
]}

Pavani, Giulia ^{[4
]}

Wang, Yongping ^{[5
,6
]}

Grupp, Stephan A. ^{[7
,8
]}

Chou, Stella T. ^{[1
,5
]}

Ni, Houping ^{[2
]}

Mui, Barbara L. ^{[9
]}

Tam, Ying K. ^{[9
]}

Weissman, Drew ^{[2
]}

Rivella, Stefano ^{[1
,10
,11
,12
,13
,14
]}

Parhiz, Hamideh ^{[2
]}

机构：

[1] Childrens Hosp Philadelphia, Dept Pediat, Hematol, Philadelphia, PA USA

[2] Univ Penn, Perelman Sch Med, Div Infect Dis, Philadelphia, PA USA

[3] Univ Michigan, Dept Pediat, Ann Arbor, MI USA

[4] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Ctr Cellular & Mol Therapeut, Philadelphia, PA USA

[5] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Transfus Med, Philadelphia, PA USA

[6] Univ Penn, Perelman Sch Med, Dept Clin Pathol & Lab Med, Philadelphia, PA USA

[7] Childrens Hosp Philadelphia, Div Oncol, Dept Pediat, Philadelphia, PA USA

[8] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA USA

[9] Acuitas Therapeut, Vancouver, BC V6T1Z3, Canada

[10] Univ Penn, Perelman Sch Med, Philadelphia, PA USA

[11] Univ Penn, Cell & Mol Biol affin Grp, Philadelphia, PA USA

[12] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA USA

[13] Childrens Hosp Philadelphia, Penn Ctr Musculoskeletal Disorders, Philadelphia, PA USA

[14] Univ Penn, Penn Inst RNA Innovat, Philadelphia, PA USA

来源：

SCIENCE | 2023年 / 381卷 / 6656期

基金：

美国国家卫生研究院;

关键词：

BONE-MARROW-TRANSPLANTATION; LONG-TERM; LATE COMPLICATIONS; CHIMERISM; RECEPTOR;

D O I：

10.1126/science.ade6967

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Hematopoietic stem cells ( HSCs) are the source of all blood cells over an individual's lifetime. Diseased HSCs can be replaced with gene-engineered or healthy HSCs through HSC transplantation (HSCT). However, current protocols carry major side effects and have limited access. We developed CD117/ LNP-messenger RNA (mRNA), a lipid nanoparticle (LNP) that encapsulates mRNA and is targeted to the stem cell factor receptor (CD117) on HSCs. Delivery of the anti-human CD117/LNP-based editing system yielded near- complete correction of hematopoietic sickle cells. Furthermore, in vivo delivery of pro-apoptotic PUMA (p53 up-regulated modulator of apoptosis) mRNA with CD117/LNP affected HSC function and permitted nongenotoxic conditioning for HSCT. The ability to target HSCs in vivo offers a nongenotoxic conditioning regimen for HSCT, and this platform could be the basis of in vivo genome editing to cure genetic disorders, which would abrogate the need for HSCT.

引用

页码：436 / 443

页数：8

共 50 条

[11] Effects of MSC Coadministration and Route of Delivery on Cord Blood Hematopoietic Stem Cell Engraftment
Carrancio, S.
Romo, C.
Ramos, T.
Lopez-Holgado, N.
Muntion, S.
Prins, H. J.
Martens, A. C.
Brinon, J. G.
San Miguel, J. F.
del Canizo, M. C.
Sanchez-Guijo, F.
CELL TRANSPLANTATION, 2013, 22 (07) : 1171 - 1183
[12] Hematopoietic Stem Cell Heterogeneity
Jurecic, Roland
STEM CELLS HETEROGENEITY IN DIFFERENT ORGANS, 2019, 1169 : 195 - 211
[13] Hematopoietic stem cell donation
Chen, Shu-Huey
Wang, Tso-Fu
Yang, Kuo-Liang
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (04) : 446 - 455
[14] Aneuploidy impairs hematopoietic stem cell fitness and is selected against in regenerating tissues in vivo
Pfau, Sarah J.
Silberman, Rebecca E.
Knouse, Kristin A.
Amon, Angelika
GENES & DEVELOPMENT, 2016, 30 (12) : 1395 - 1408
[15] Hematopoietic Stem Cell Transplantation in Severe Congenital Neutropenia
Carlsson, G.
Winiarski, J.
Ljungman, P.
Ringden, O.
Mattsson, J.
Nordenskjold, M.
Touw, I.
Henter, J-I
Palmblad, J.
Fadeel, B.
Hagglund, H.
PEDIATRIC BLOOD & CANCER, 2011, 56 (03) : 444 - 451
[16] Secondary malignancies after hematopoietic stem cell transplantation
Roziakova, L.
Bojtarova, E.
Mistrik, M.
Mladosievicova, B.
NEOPLASMA, 2011, 58 (01) : 1 - 8
[17] Sequential kidney and allogeneic hematopoietic stem cell transplantation
Tanase, Alina D.
Sinescu, Ioanel
Baston, Catalin
Tacu, Dorina
Domnisor, Liliana
Stefan, Laura
Ranete, Adela
Lipan, Lavinia
Craciun, Oana
Manea, Ioan
Bumbea, Horia
Ciurea, Stefan O.
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (10) : E267 - E270
[18] Hematopoietic Stem Cell Transplantation in Sickle Cell Disease: A Multidimentional Review
Rostami, Tahereh
Rad, Soroush
Rostami, Mohammad Reza
Mirhosseini, Seied Amirhossein
Alemi, Hediyeh
Khavandgar, Naghmeh
Janbabai, Ghasem
Kiumarsi, Azadeh
Kasaeian, Amir
Mousavi, Seied Asadollah
CELL TRANSPLANTATION, 2024, 33
[19] Assessment of donor cell engraftment after hematopoietic stem cell transplantation for sickle cell disease: A review of current and future methods
Lewis, Jasmine
Greenway, Steven C.
Khan, Faisal
Singh, Gurpreet
Bhatia, Monica
Guilcher, Gregory M. T.
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (10) : 1359 - 1371
[20] Robust CAR-T memory formation and function via hematopoietic stem cell delivery
Zhen, Anjie
Carrillo, Mayra A.
Mu, Wenli
Rezek, Valerie
Martin, Heather
Hamid, Philip
Chen, Irvin S. Y.
Yang, Otto O.
Zack, Jerome A.
Kitchen, Scott G.
PLOS PATHOGENS, 2021, 17 (04)

← 1 2 3 4 5 →